Sign in

CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
  1. 144 Insider Sale of Securities
  2. SCHEDULE 13D/A Stake Beneficial Ownership Report
  3. 4 Open-market buy Director bought 300,000 shares at $16.00 ($4,800,000)
  4. 4 Planned sale President and COO sold 3,631 shares at $18.04 ($65,501)
  5. 8-K Event Material agreement · Results of operations
  6. 424B5 Offering Prospectus
  7. 144 Insider Sale of Securities
  8. FWP Offering Free Writing Prospectus
  9. 424B5 Offering Prospectus
  10. 8-K Event Other events
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Planned sale President and COO sold 3,828 shares at $18.10 ($69,296)

Page 6 of 14 · 266 filings